Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.12% |
| 2 | Technology | 12.96% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
MasTec
MTZ
$22.7B
| $1.03M | ﹤0.01% |
+27,000
| New | +$916K |
|
|
IEC
2527
DELISTED
IEC Electronics Corp.
IEC
| $1.03M | ﹤0.01% |
289,300
+32,000
| +12% | +$120K |
|
|
HOLI
2528
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $1.03M | ﹤0.01% |
56,205
+21,187
| +61% | +$420K |
|
2529
Scully Royalty
SRL
$75.4M
| $1.02M | ﹤0.01% |
105,143
+13,100
| +14% | +$134K |
|
|
FCCY
2530
DELISTED
1st Constitution Bancorp
FCCY
| $1.02M | ﹤0.01% |
+54,600
| New | +$818K |
|
|
AXAS
2531
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.02M | ﹤0.01% |
+19,856
| New | +$782K |
|
2532
Flexsteel Industries
FLXS
$307M
| $1.02M | ﹤0.01% |
16,500
-9,685
| -37% | -$503K |
|
|
APTS
2533
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $1.01M | ﹤0.01% |
68,000
-11,400
| -14% | -$152K |
|
2534
Upland Software
UPLD
$13.3M
| $1.01M | ﹤0.01% |
11,300
+680
| +6% | +$59.9K |
|
2535
Alphatec Holdings
ATEC
$1.48B
| $1.01M | ﹤0.01% |
313,545
+144,300
| +85% | +$782K |
|
2536
CytomX Therapeutics
CTMX
$690M
| $1M | ﹤0.01% |
+91,200
| New | +$1.1M |
|
|
CRHM
2537
DELISTED
CRH Medical Corporation
CRHM
| $1M | ﹤0.01% |
190,600
-41,300
| -18% | -$209K |
|
|
PPIH
2538
Perma-Pipe International
PPIH
$189M
| $1M | ﹤0.01% |
123,500
+13,800
| +13% | +$111K |
|
|
ENG
2539
DELISTED
ENGlobal Corp
ENG
| $998K | ﹤0.01% |
52,204
+9,625
| +23% | +$118K |
|
|
KW
2540
DELISTED
Kennedy-Wilson Holdings
KW
| $995K | ﹤0.01% |
48,520
-78,480
| -62% | -$1.68M |
|
|
EHIC
2541
DELISTED
eHi Car Services Limited
EHIC
| $987K | ﹤0.01% |
108,900
+82,400
| +311% | +$830K |
|
|
LOAN
2542
Manhattan Bridge Capital
LOAN
$48M
| $984K | ﹤0.01% |
129,500
+25,400
| +24% | +$172K |
|
|
SGMO
2543
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $982K | ﹤0.01% |
321,819
-272,681
| -46% | -$993K |
|
|
GST
2544
DELISTED
Gastar Exploration Inc.
GST
| $980K | ﹤0.01% |
632,554
+532,580
| +533% | +$643K |
|
|
SHLM
2545
DELISTED
Schulman (A.) Inc
SHLM
| $975K | ﹤0.01% |
+29,141
| New | +$924K |
|
2546
Sinclair Inc
SBGI
$1.02B
| $973K | ﹤0.01% |
29,171
-490,921
| -94% | -$14.6M |
|
2547
Virco
VIRC
$94.8M
| $973K | ﹤0.01% |
226,300
-5,700
| -2% | -$24K |
|
2548
TIM SA
TIMB
$9.1B
| $968K | ﹤0.01% |
82,000
-111,238
| -58% | -$1.39M |
|
|
HSTO
2549
DELISTED
Histogen Inc. Common Stock
HSTO
| $968K | ﹤0.01% |
919
+606
| +194% | +$275K |
|
2550
Aspen Aerogels
ASPN
$339M
| $964K | ﹤0.01% |
233,300
-100
| -0% | -$487 |
|
Similar funds
Renaissance Technologies's Q4 2016 Portfolio in Review
As of Q4 2016, Renaissance Technologies held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Renaissance Technologies deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Renaissance Technologies's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Renaissance Technologies's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Renaissance Technologies fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Renaissance Technologies's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Renaissance Technologies opened 418 new positions and closed 494 in Q4 2016.
- Renaissance Technologies's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.